Conceptualising specialist supportive clinical management (SSCM): current evidence and future directions
  • Description

    Abstract Background Current evidence-based treatments for adult anorexia nervosa (AN) have limitations, with high attrition, very poor outcomes for 20% of people, and no clearly superior manualised therapy for adults with AN. Specialist Supportive Clinical Management (SSCM) was designed as a control treatment but has evolved as a valid first line treatment. The present paper aims to provide an overview of the evidence base for SSCM and a pedagogical reconceptualization with expansion by theoretical integration (TI). Body A secondary meta-analysis endorses SSCM as a promising treatment. This paper positions SSCM as a manualised therapy for adult AN with six unique features, namely (1) a philosophy which is person-centred, non-prescriptive, and informed by the person’s strengths and values, (2) a focus on the person through inclusion of supportive psychotherapy and problem (clinical management), within target symptoms as defined in relation to AN, (3) a flexible and responsive therapy that could be delivered by a variety of clinicians with experience treating AN (4) a commitment to reversing starvation though a directional approach and a defined yet flexible stance on dietetic intervention (5) a commitment to the therapeutic relationship within all three phases of treatment, and (6) a therapy ‘uncluttered’ by specific mandates. In addition, this paper positions SSCM as a treatment that may be strengthened by other modalities and may also be adapted to the treatment of other eating disorders (ED), not just AN. The level of therapist sophistication to deliver upon the supportive psychotherapy component is explored and future directions are offered. Conclusion SSCM is a unique and valid first line treatment for AN and would benefit from further expansion in line with emerging understandings of AN to strengthen it as a treatment. Speculation on aspects of potency would benefit from further testing. The proposed re-conceptualisation of SSCM in the context of its evidence may strengthen it as a treatment overall, position it as adaptable for treatment of other eating disorders and make it more accessible to clinicians.
    • - Start
      Data publication title Conceptualising specialist supportive clinical management (SSCM): current evidence and future directions
    • Description

      Abstract Background Current evidence-based treatments for adult anorexia nervosa (AN) have limitations, with high attrition, very poor outcomes for 20% of people, and no clearly superior manualised therapy for adults with AN. Specialist Supportive Clinical Management (SSCM) was designed as a control treatment but has evolved as a valid first line treatment. The present paper aims to provide an overview of the evidence base for SSCM and a pedagogical reconceptualization with expansion by theoretical integration (TI). Body A secondary meta-analysis endorses SSCM as a promising treatment. This paper positions SSCM as a manualised therapy for adult AN with six unique features, namely (1) a philosophy which is person-centred, non-prescriptive, and informed by the person’s strengths and values, (2) a focus on the person through inclusion of supportive psychotherapy and problem (clinical management), within target symptoms as defined in relation to AN, (3) a flexible and responsive therapy that could be delivered by a variety of clinicians with experience treating AN (4) a commitment to reversing starvation though a directional approach and a defined yet flexible stance on dietetic intervention (5) a commitment to the therapeutic relationship within all three phases of treatment, and (6) a therapy ‘uncluttered’ by specific mandates. In addition, this paper positions SSCM as a treatment that may be strengthened by other modalities and may also be adapted to the treatment of other eating disorders (ED), not just AN. The level of therapist sophistication to deliver upon the supportive psychotherapy component is explored and future directions are offered. Conclusion SSCM is a unique and valid first line treatment for AN and would benefit from further expansion in line with emerging understandings of AN to strengthen it as a treatment. Speculation on aspects of potency would benefit from further testing. The proposed re-conceptualisation of SSCM in the context of its evidence may strengthen it as a treatment overall, position it as adaptable for treatment of other eating disorders and make it more accessible to clinicians.
      • Data type dataset
    • Keywords
      • 59999 Environmental Sciences not elsewhere classified
      • FOS: Biological sciences
      • FOS: Earth and related environmental sciences
      • Computational Biology
      • 69999 Biological Sciences not elsewhere classified
      • Ecology
      • Pharmacology
      • Science Policy
      • Cancer
    • Funding source
    • Grant number(s)
      • -
      • FoR codes
      SEO codes
    - Coverage
      Temporal (time) coverage
    • Start date
    • End date
      • Time period
       
      Spatial (location,mapping) coverage
    • Locations
    - Data
    - Supplements
    • Related publications
    • Related website
        Name
      • URL
      • Notes
    • Related metadata (including standards, codebooks, vocabularies, thesauri, ontologies)
    • Related data
        Name
      • URL
      • Notes
    • Related services
        Name
      • URL
      • Notes
    - License
      The data will be licensed under
    • Other license
      • Statement of rights in data Copyright Western Sydney University
    - Citation
      Citation Kiely, Laura; Conti, Janet; Hay, Phillipa (2022): Conceptualising specialist supportive clinical management (SSCM): current evidence and future directions. Figshare. https://doi.org/10.6084/m9.figshare.c.5881450.v1

    © 2021 Queensland Cyber Infrastructure Foundation